The loss of SIRT2 inhibits the activation of AMPK, promotes ageing‐related and/or angiotensin II (Ang II)‐induced pathological cardiac hypertrophy and weakens the metformin‐mediated cardiac protection. This evidence concerns the gene AGT and cardiac hypertrophy.